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OBJECTIVES We sought to assess the relation between serum neopterin concentration and complex
coronary artery stenosis in patients with unstable angina.
BACKGROUND Monocyte activation is associated with acute atheromatous plaque disruption and acute
coronary syndromes. Angiographically demonstrated complex coronary stenosis is often an
expression of plaque disruption. Increased serum concentration of neopterin, a pterydine
derivative secreted by macrophages after stimulation by interferon-gamma, has been observed
in patients with acute coronary syndromes as compared with control subjects and patients
with stable angina pectoris.
METHODS We studied 50 patients with unstable angina (32 men) who underwent coronary angiography
after hospital admission. All coronary stenoses with $30% diameter reduction were assessed
and classified as “complex” (irregular or scalloped borders, ulceration or filling defects
suggesting thrombi) or “smooth” (absence of complex features). Serum neopterin levels were
assessed within 24 h of hospital admission using a commercially available immunoassay
(enzyme-linked immunosorbent assay kit, IBL, Hamburg, Germany).
RESULTS Thirty-nine patients were classified in Braunwald class IIIb, four in class IIb and seven in class
Ib. The number of complex lesions per patient was 2.6 6 1.8 (mean 6 SD). The mean
neopterin concentration was 7.76 6 3.62 nmol/liter. A significant correlation was observed
between neopterin serum concentration and the presence of complex coronary stenoses (r 5
0.35, p 5 0.015). Multiple regression analysis showed that serum neopterin (p , 0.0001) was
independently associated with the number of complex lesions. Other variables associated with
complex lesions were the number of vessels with $75% stenosis (p , 0.0001), plasma
creatinine (p 5 0.003), triglycerides (p 5 0.014) and a history of unstable angina (p 5 0.032).
CONCLUSIONS Serum neopterin concentration is associated with the presence of angiographically demon-
strated complex lesions in patients with unstable angina and may represent a marker of
coronary disease activity. (J Am Coll Cardiol 2000;35:956–62) © 2000 by the American
College of Cardiology
Disruption of vulnerable atheromatous plaque is the most
common pathogenic mechanism in acute coronary syn-
dromes (1). There is increasing evidence that inflammation
plays an important role in atherogenesis and may determine
plaque vulnerability (2). Recent observations suggest that
vulnerable atherosclerotic plaques have an increased number
of both macrophages and activated lymphocytes (3). In
addition, in previous studies it has been shown that a large
lipid core occupying a large proportion of plaque volume
and a thin, fibrous plaque cap are of crucial importance for
plaque disruption (4,5). Compared with patients with
chronic stable angina, patients with acute coronary syn-
dromes have coronary plaques with more extensive
macrophage-rich areas (6). Activated macrophages within
plaques are capable of producing a range of proteases that
lead to proteolytic destruction of the connective tissue
matrix (7) and may contribute to the “active” phenomenon
of plaque disruption (8). Unstable plaques also contain
activated T cells that produce the cytokine interferon-
gamma (IFN-gamma), which both activates macrophages
present in the atheromatous plaque and interferes with
plaque matrix collagen synthesis (9).
Neopterin, a pterydine derivative, is secreted by macro-
phages after stimulation by IFN-gamma (10) and has been
shown to be elevated in the serum of patients with unstable
angina and acute myocardial infarction as compared with
control subjects and patients with stable angina pectoris
(11,12). It has also been established that patients with
unstable angina have a higher incidence of angiographically
demonstrated complex coronary stenoses as compared with
patients with stable angina (13). Complex lesions are
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associated with rapid disease progression (14,15) and a
higher restenosis rate after percutaneous transluminal coro-
nary angioplasty as compared with smooth lesions, probably
reflecting a tendency toward thrombogenesis or further
plaque disruption, or both (16). The aim of this study was
to assess whether serum neopterin concentration is related
to the presence of angiographically demonstrated complex
lesions in patients with unstable angina.
METHODS
Patients. We studied 50 patients (32 men) who were
admitted to the Coronary Care Unit of St. George’s
Hospital in London between September 1996 and June
1997 with the diagnosis of unstable angina and who
underwent coronary arteriography after hospital admission.
Unstable angina was defined and classified according to
Braunwald (17). Class I indicates new onset or severe,
accelerated angina; class II indicates angina at rest during
the previous month before admission but not within the last
48 h before admission; and class III indicates angina at rest
during the last 48 h before admission. All patients had
primary unstable angina, corresponding to subclass “b” of
Braunwald’s classification (17). These patients were part of
a larger cohort of 101 consecutive patients with unstable
angina, 13 of whom developed a Q wave myocardial
infarction, according to electrocardiographic (ECG) crite-
ria, and had raised creatine kinase (CK) and CK, MB
fraction levels during the first 48 h of admission, and seven
of whom were excluded owing to ongoing systemic or
cardiac inflammatory processes. Also excluded were 31
patients who did not undergo coronary angiography. The
patients’ clinical management and the decision to proceed
with cardiac catheterization was left to the discretion of the
managing cardiologist. Thirty-nine patients were in Braun-
wald class IIIb, seven were in class Ib and four were in class
IIb. All had a transient ECG diagnostic of myocardial
ischemia. The patients’ baseline clinical characteristics at
initial presentation are summarized in Table 1. All patients
gave written, informed consent before study entry, and the
study was approved by the local Ethics Committee.
Neopterin measurements. Neopterin serum concentration
was measured using a commercially available immunoassay
(enzyme-linked immunosorbent assay kit, IBL, Hamburg,
Germany). The limit of detection was 1.5 nmol/liter. The
analytic precision of the assay was ,3% at the level of 7.7
nmol/liter, and ,4% at the level of 20 nmol/liter. All other
biochemistry measurements were carried out by the Analy-
tical Unit of the Biochemistry Department of our institu-
tion, using standard methods.
Angiographic analyses. Coronary angiography was carried
out according to the Judkins technique, and images of the
coronary tree were obtained in routine, standardized pro-
jections with the digital Philips Integris 3000 system (Phil-
ips, Holland) in all patients. Two experienced cardiologists
who had no knowledge of the patients’ clinical characteris-
tics and biochemical results visually reviewed all angio-
graphic images to assess the extent of coronary artery disease
and morphology of all coronary artery stenoses with $30%
reduction in diameter.
ANGIOGRAPHIC SCORING SYSTEM (THE SULLIVAN SCORE).
Sullivan’s scoring system (18) was used to assess the exten-
sion of atherosclerotic disease in the coronary artery tree, as
described in previous studies from our group (19). An
example is shown in Figure 1. Coronary angiograms were
assessed and scored according to the system of Sullivan et al.
(18), which includes vessel score, stenosis score and exten-
sion score. Vessel score is based on the number of coronary
arteries showing $75% stenosis reduction in lumen diam-
eter. Stenosis score is aimed at reflecting the most severe
Abbreviations and Acronyms
CK 5 creatine kinase
ECG 5 electrocardiogram, electrocardiographic
IFN-gamma 5 interferon-gamma
Table 1. Baseline Variables, Risk Factors, Past Medical History
and Treatment at Hospital Admission in 50 Patients With
Unstable Angina
n (%)
Male gender 32 (64)
Diabetes mellitus 5 (10)
Braunwald class IIIb 39 (78)
Hypertension 24 (48)
Dislipidemia 26 (52)
Peripheral vascular disease 5 (10)
Stroke 3 (6)
Smoking status
Ex-smoker 13 (26)
Current 13 (26)
Family history
Relatives #55 years 6 (12)
Relatives .55 years 26 (52)
Previous myocardial infarction 27 (54)
Previous unstable angina 22 (44)
Surgical coronary revascularization 11 (22)
Treatment on admission
ACE inhibitors 9 (18)
Calcium channel antagonists 26 (52)
Beta-blockers 18 (36)
Aspirin 34 (68)
Digoxin 5 (10)
Diuretics 13 (26)
Nitrates 24 (48)
Warfarin 3 (6)
Lipid-lowering agents 15 (30)
ACE 5 angiotensin converting enzyme.
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stenosis observed in each of the main coronary vessels
assessed. Grading is as follows: grade 1 5 1% to 49%
reduction in coronary lumen diameter; grade 2 5 stenosis
with 50% to 74% reduction in lumen diameter; grade 3 5
stenosis with 75% to 99% reduction in lumen diameter; and
grade 4 5 total coronary occlusions. Finally, extension score
refers to the proportion of the coronary artery tree showing
angiographically detectable atheroma. The observed pro-
portion in each vessel is multiplied by a factor that varies
according to the artery involved: left main stem, 5; left
anterior descending coronary artery, 20; main diagonal
branch, 10; first septal perforator, 5; left circumflex artery,
20; obtuse marginal and posterolateral vessels, 10; right
coronary artery, 20; and main posterior descending branch,
10. When the major lateral wall branch was a large obtuse
marginal or intermediate vessel, this was given a factor of
20, and the left circumflex artery, a factor of 10. When a
vessel was occluded and the distal bed was not fully
visualized by collateral flow, the proportion of vessel not
visualized was given the mean extent score of the remain-
ing vessels. The scores for each vessel or branch were
added to give a total score out of 100; this total score
represents the percentage of the coronary luminal surface
area involved by atheroma (18). Interobserver variability
(the standard deviation of the mean unsigned difference
between paired estimates) for the extent score in this
study was 4.9%.
ANGIOGRAPHIC CORONARY STENOSIS MORPHOLOGY. All
coronary stenoses with $30% diameter reduction were
assessed by two experienced cardiologists who had no
knowledge of the neopterin results or the identity and
clinical characteristics of the patients. Stenosis morphology
was assessed as reported previously in several studies from
our group (14,19–21). Briefly, stenoses were considered to
be complex or smooth. Complex lesions were defined by the
following features: 1) irregular morphology or scalloped
borders, or both; 2) overhanging or abrupt edges perpen-
dicular to the vessel wall; 3) ulceration (i.e., outpouchings
within the stenosis); and/or 4) the presence of filling defects
consistent with intracoronary thrombus (22). Coronary
stenoses with no complex features were classified as smooth
lesions. When discrepancies arose regarding the morpho-
logic appearance of a lesion, a third experienced observer
was involved, and the lesion was classified by consensus.
The reproducibility of the morphologic classification was
determined by repeat analysis at .3-month intervals inde-
pendently by two observers who had no knowledge of the
stenosis classification obtained at the first reading. Interob-
server agreement regarding qualitative morphologic analyses
of all significant stenoses was 97%.
Statistical analysis. Results for normally distributed con-
tinuous variables are expressed as the mean value 6 SD, and
continuous variables with non-normal distribution are pre-
sented as the median value (interquartile interval). Contin-
uous variables were analyzed using the unpaired t test and
the Mann-Whitney U test, as appropriate. The Spearman
two-way test was used to assess the relation between two
quantitative variables with non-normal distribution. The
Pearson two-way test was used to assess the relation
between two quantitative variables with normal distribu-
tions. We assessed independent predictors of complex
stenoses using multiple regression analysis. As it has been
established that renal function is a major determinant of
neopterin levels in blood (23), neopterin levels were adjusted
for creatinine levels when correlated with other variables.
Creatinine was included in the multiple regression analysis
where the dependent variable was the number of complex
lesions, and the independent variables were those which
showed, on univariate analysis, a significant correlation with
the number of complex lesions. Differences were considered
to be statistically significant if the null hypothesis could be
Figure 1. A, Representative angiogram of a patient with one-
vessel disease (obtuse marginal vessel with .75% stenosis). The
right coronary artery was completely normal. B, Angiographic
scores as suggested by Sullivan et al. (18), with the final (total)
score along the bottom (see text for details).
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rejected with .95% confidence. The SPSS 7.0 statistical
software package was used for all calculations.
RESULTS
The baseline clinical characteristics and angiographic results
in the 50 patients (32 men) included in the study are shown
in Tables 1 and 2, respectively.
Eighty percent of patients had complex lesions .30%;
three patients had complex lesions only; seven patients had
smooth lesions only; and three patients had no stenoses
$30%. In 30 patients, both complex and smooth stenoses
were observed.
Univariate analysis revealed that age, neopterin serum
concentration and angiographic stenosis severity were sig-
nificantly correlated with the number of complex lesions
(Table 3), as were the use of digoxin (p 5 0.029) and
nitrates (p 5 0.048). Complex stenosis morphology was
associated, albeit nonsignificantly, with a history of unstable
angina (p 5 0.08) and unstable angina (Braunwald class
IIIb) on hospital admission (p 5 0.096).
As expected, serum neopterin concentration showed a
significant correlation with creatinine levels (r 5 0.34, p 5
0.014). Neopterin also showed a highly significant correla-
tion with the number of complex lesions (r 5 0.35, p 5
0.015) (Table 3). Neopterin, however, was not significantly
associated with disease extent and severity, as assessed by
vessel score, stenosis score and extension score. Similarly,
neopterin levels were not associated with the number of
smooth coronary stenoses or left ventricular ejection fraction
(Table 4).
Interestingly, women had significantly higher adjusted
neopterin levels than did men (mean difference, 3.25 nmol/
liter [95% confidence interval 1.24 to 5.27], p 5 0.002) and
a trend toward less severe coronary artery disease. Figure 2
shows scatter plots for neopterin levels and the number of
complex lesions in men and women.
White blood cell (r 5 20.012, p 5 0.94) and monocyte
(r 5 20.072, p 5 0.64) counts were not significantly
associated with neopterin levels in our study. Similarly, we
did not observe an association between the time elapsed
from the last episode of angina and the drawing of blood
samples for the assessment of neopterin (r 5 0.031, p 5
0.83). We performed backward stepwise multiple regression
analysis where we included both the variables shown to have
a relation with complex lesions in the univariate analysis and
the variables showing a trend (p , 0.20). Creatinine was
also included in the model, as this variable is known to have
a direct effect on neopterin levels. We found that the
following variables remained independent predictors of the
number of complex lesions in this model: neopterin (p ,
0.001), vessel score (p 5 0.001), plasma creatinine (p 5
0.003), plasma triglycerides (p 5 0.01) and a history of
unstable angina (p 5 0.03) (Table 5). Multiple regression
analysis showed that neopterin level and the number of
diseased vessels were the most important predictors of the
number of angiographically demonstrated complex stenoses.
Findings in this multiple regression analysis model explain
69% of the variation in the number of complex lesions
(adjusted r2 5 0.69).
Table 2. Baseline Variables and Coronary Angiography in 50
Patients With Unstable Angina
Mean 6 SD or Median
(Interquartile Range)
Age (yrs) 62.84 6 9.86
BMI (kg/m2) 27.00 6 3.91
Diastolic BP (mm Hg) 77 6 14
Systolic BP (mm Hg) 136 6 20
Biochemistry
Cholesterol (mmol/liter) 5.60 6 1.09
HDL cholesterol (mmol/liter) 1.10 6 0.33
Triglycerides (mmol/liter) 1.55 (0.95–2.43)
Creatine kinase (U/liter) 100.52 6 47.19
Creatinine (mmol/liter) 99.28 6 41.48
Neopterin (nmol/liter) 7.76 6 3.62
Angiography
Vessel score (n) 2.0 (1.0–3.0)
Stenosis score (units) 10.40 6 5.20
Extension score (%) 24.64 6 14.85
Ejection fraction (%) 58.38 6 14.36
Smooth lesions (n) 2.4 6 1.6
Complex lesions (n) 2.6 6 1.8
BMI 5 body mass index; BP 5 blood pressure; HDL 5 high density lipoprotein.
Table 3. Univariate Correlation (r Value) Among Baseline
Variables and Complex Coronary Artery Stenoses in 50 Patients
With Unstable Angina
r Value p Value
Age (yrs) 0.38 0.006
BMI (kg/m2) 0.17 0.33
Diastolic BP (mm Hg) 0.15 0.30
Systolic BP (mm Hg) 0.22 0.13
Biochemistry
Cholesterol (mmol/liter) 0.14 0.33
HDL cholesterol (mmol/liter) 20.20 0.19
Triglycerides (mmol/liter) 0.28 0.06*
Creatine kinase (U/liter) 0.10 0.50
Creatinine (mmol/liter) 0.23 0.12
Neopterin (nmol/liter) 0.35 0.015
Angiography
Vessel score (n) 0.74 , 0.0001
Stenosis score (units) 0.79 , 0.0001
Extension score (%) 0.77 , 0.0001
Ejection fraction (%) 20.42 0.007
Smooth lesions (n) 0.16 0.26
*Two-way Spearman correlation test. When neopterin was corrected by creatinine,
p 5 0.04.
Abbreviations as in Table 2.
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DISCUSSION
In this study, we have assessed for the first time, to our
knowledge, the relation between serum neopterin concen-
tration and angiographically demonstrated complex stenoses
in patients with unstable angina pectoris.
Neopterin and coronary artery disease activity. We ob-
served that neopterin levels had a significant relation with
the number of complex lesions. However, neopterin levels
did not correlate with vessel score, number of smooth
lesions or stenosis severity. This finding is in contrast to a
recent study where neopterin was found to correlate with
the extent of coronary artery disease (24). The study by
Gurfinkel et al. (24), however, included a small number of
patients; multiple regression analysis was not performed to
assess whether neopterin was independently associated with
the extent of coronary artery disease; and neopterin levels
were not adjusted for creatinine levels.
Our findings suggest that neopterin may be a marker of
coronary disease activity rather than a measure of the
anatomic extent of coronary artery disease. The results of
the present study are more expansive than those of previous
studies from our group (11), which showed that neopterin is
elevated in patients with unstable angina and in patients
with acute myocardial infarction as compared with patients
with chronic myocardial infarction and normal control
subjects. Further, support to the notion that neopterin is a
marker of plaque activity is provided by a recent study of
Schumacher et al. (12), who showed that neopterin was
elevated in patients with acute myocardial infarction
(mean 6 SD, 13.7 6 2.4 nmol/liter) as compared with
patients with chronic stable angina (8.6 6 3.4 nmol/liter) or
healthy control subjects (6.8 6 1.8 nmol/liter). Neopterin
levels in patients with chronic stable angina in Schumacher
et al.’s report (12) were not related to the number of
diseased coronary vessels.
Neopterin, inflammation and complex lesions. The
present study specifically assessed whether a relation exists
between serum neopterin concentration, a marker of mac-
rophage activity, and angiographically demonstrated com-
plex stenoses in patients with unstable angina pectoris.
Compared with patients with stable angina pectoris, those
with unstable angina have a higher number of complex
coronary lesions (22,25). It has been shown that the
progression of these stenoses is faster than that of smooth
stenoses. A larger proportion of complex stenoses, as com-
pared with smooth stenoses, progress rapidly in both pa-
tients with stabilized unstable angina (21) and those with
chronic stable angina (14). It has been suggested that
angiographically demonstrated complex lesions represent
vulnerable plaques prone to disruption or truly disrupted
plaques (5,6,22). Plaque vulnerability is a function of the
increased number of macrophages and activated lympho-
cytes (4). Coronary plaques of patients with unstable angina
have more extensive macrophage-rich areas than those of
patients with stable angina (3,6). These macrophages appear
to play a key role in weakening the fibrous cap of athero-
sclerotic plaques by secreting proteases that contribute to
the “active” phenomenon of plaque disruption (8). Vulner-
able plaques also have activated T cells that produce the
cytokine IFN-gamma and activate the macrophages (9,26).
Importantly, IFN-gamma–stimulated macrophages produce
neopterin (10). The results of our study lend further support
to the notion that inflammatory processes (as shown with
C-reactive protein and serum amyloid A protein) (27,28)
Figure 2. Relation between neopterin levels and complex coronary
artery stenoses in men and women (see text for details).
Table 4. Univariate Correlation Between Serum Neopterin
Levels and Angiographic Data
r
Value
p
Value
r
Value*
p
Value*
Vessel score 0.08 0.59† 20.11 0.45†
Stenosis score 0.15 0.29 0.10 0.50
Extension score 0.16 0.26 0.11 0.46
No. of smooth stenoses 20.20 0.16 20.21 0.16
No. of complex stenoses 0.35 0.015 0.35 0.012
Total no. of stenoses 0.16 0.26 0.17 0.25
Ejection fraction (%) 20.082 0.26 20.12 0.49
*Neopterin was adjusted by creatinine and gender. Two-way Pearson or †Spearman
correlation test.
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and immune activation may play a pathogenic role in acute
coronary syndromes (28,29). White blood cell and mono-
cyte counts were not associated with neopterin in our study.
This finding is not surprising, as neopterin production is
more likely to be the expression of monocyte activation than
of increased monocyte number (10). We observed no
relation between the time elapsed between the last episode
of pain and neopterin levels. Again, neopterin levels are
most probably the result of immune activation related to the
atherogenic process, as well as the inflammatory mechanism
that leads to acute coronary events. It is unlikely that this
molecule represents a marker of transient ischemia.
Complex lesions and independent predictors by multiple
regression analysis. Our findings in the present study—
mainly that in patients with rapidly stabilized unstable
angina, the number of complex lesions correlates with serum
neopterin concentration and triglyceride levels—are consis-
tent with previous observations that contributed to our
current pathophysiologic knowledge regarding acute coro-
nary syndromes (30–35). Interestingly, in the present study,
we confirmed the previous findings of our group—that is, a
past history of unstable angina is an independent predictor
of the number of complex coronary stenoses and is associ-
ated with rapid coronary stenosis progression (36). In this
study, multiple regression analysis showed that serum cre-
atinine levels remained significantly associated with the
number of complex lesions, probably reflecting the previ-
ously described close relation between neopterin and creat-
inine concentrations (23).
Conclusions. Our study has shown that neopterin serum
concentration is independently related to the number of com-
plex stenoses in patients with unstable angina, even after
adjustment for confounding variables. This study gives support
to the hypothesis that activation of immune cells in angio-
graphically complex plaques may play a pathogenic role in
unstable coronary syndromes. Neopterin serum concentration
may be a useful clinical marker of disease activity (37), and
further studies are necessary to substantiate this.
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